Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'uPA' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 211 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Togel, F; Datta, C; Badbaran, A; Kroger, N; Renges, H; Gieseking, F; Janicke, F; Zander, AR; Kruger, W
      Urokinase-like plasminogen activator receptor expression on disseminated breast cancer cells

      JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH
    2. Muehlenweg, B; Sperl, S; Magdolen, V; Schmitt, M; Harbeck, N
      Interference with the urokinase plasminogen activator system: a promising therapy concept for solid tumours

      EXPERT OPINION ON BIOLOGICAL THERAPY
    3. Lutz, V; Reuning, U; Kruger, A; Luther, T; von Steinburg, SP; Graeff, H; Schmitt, M; Wilhelm, OG; Magdolen, V
      High level synthesis of recombinant soluble urokinase receptor (CD87) by ovarian cancer cells reduces intraperitoneal tumor growth and spread in nudemice

      BIOLOGICAL CHEMISTRY
    4. Matulic, M; Brdar, B
      Induction of urokinase-type plasminogen activator by sodium salicylate in a glioblastoma cell strain

      FOOD TECHNOLOGY AND BIOTECHNOLOGY
    5. Obiezu, CV; Scorilas, A; Katsaros, D; Massobio, M; Yousef, GM; Fracchioli, S; de la Longrais, IAR; Arisio, R; Diamandis, EP
      Higher human kallikrein gene 4 (KLK4) expression indicates poor prognosis of ovarian cancer patients

      CLINICAL CANCER RESEARCH
    6. Konecny, G; Untch, M; Pihan, A; Kimmig, R; Gropp, M; Stieber, P; Hepp, H; Slamon, D; Pegram, M
      Association of urokinase-type plasminogen activator and its inhibitor withdisease progression and prognosis in ovarian cancer

      CLINICAL CANCER RESEARCH
    7. Lakka, SS; Bhattacharya, A; Mohanam, S; Boyd, D; Rao, JS
      Regulation of the uPA gene in various grades of human glioma cells

      INTERNATIONAL JOURNAL OF ONCOLOGY
    8. Takanami, I; Takeuchi, K; Karuke, M
      Expression of Ets-1 is correlated with urokinase-type plasminogen activator and poor prognosis in pulmonary adenocarcinoma

      TUMOR BIOLOGY
    9. Konno, H; Abe, J; Kaneko, T; Baba, M; Shoji, A; Sunayama, K; Kamiya, K; Tanaka, T; Suzuki, S; Nakamura, S; Urano, T
      Urokinase receptor and vascular endothelial growth factor are synergistically associated with the liver metastasis of colorectal cancer

      JAPANESE JOURNAL OF CANCER RESEARCH
    10. Madhusudhan, MS; Vishveshwara, S
      Computer modeling of human angiogenin-dinucleotide substrate interaction

      PROTEINS-STRUCTURE FUNCTION AND GENETICS
    11. Chappuis, PO; Dieterich, B; Sciretta, V; Lohse, C; Bonnefoi, H; Remadi, S; Sappino, AP
      Functional evaluation of plasmin formation in primary breast cancer

      JOURNAL OF CLINICAL ONCOLOGY
    12. Underwood, PA; Bean, PA; Cubeddu, L
      Human endothelial cells grow poorly on vitronectin: Role of PAI-1

      JOURNAL OF CELLULAR BIOCHEMISTRY
    13. Taponeco, F; Curcio, C; Giuntini, A; Nardini, V; Fornaciari, G; Artini, PG; D'Ambrogio, G; Genazzini, AR
      Expression and prognostic significance of urokinase and plasminogen activator inhibitor type-1 in endometrial hyperplasia and cancer

      JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
    14. Wurfel, J; Seiter, S; Stassar, M; Claas, A; Klas, R; Rosel, M; Marhaba, R; Savelyeva, L; Schwab, M; Matzku, S; Zoller, M
      Cloning of the human homologue of the metastasis-associated rat C4.4A

      GENE
    15. Brooks, TD; Slomp, J; Quax, PHA; De Bart, ACW; Spencer, MT; Verheijen, JH; Charlton, PA
      Antibodies to PAI-1 alter the invasive and migratory properties of human tumour cells in vitro

      CLINICAL & EXPERIMENTAL METASTASIS
    16. He, C; He, P; Liu, LP; Zhu, YS
      Analysis of expressions of components in the plasminogen activator system in high- and low-metastatic human lung cancer cells

      JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
    17. Tuck, AB; Hota, C; Chambers, AF
      Osteopontin(OPN)-induced increase in human mammary epithelial cell invasiveness is urokinase (uPA)-dependent

      BREAST CANCER RESEARCH AND TREATMENT
    18. Kiss, A; Schnur, J; Szabo, Z; Nagy, P
      Immunohistochemical analysis of atypical ductular reaction in the human liver, with special emphasis on the presence of growth factors and their receptors

      LIVER
    19. Tecimer, C; Doering, DL; Goldsmith, LJ; Meyer, JS; Abdulhay, G; Wittliff, JL
      Clinical relevance of urokinase-type plasminogen activator, its receptor, and its inhibitor type 1 in endometrial cancer

      GYNECOLOGIC ONCOLOGY
    20. Romer, J; Pyke, C; Lund, LR; Ralfkiaer, E; Dano, K
      Cancer cell expression of urokinase-type plasminogen activator receptor mRNA in squamous cell carcinomas of the skin

      JOURNAL OF INVESTIGATIVE DERMATOLOGY
    21. Hiroumi, H; Dosaka-Akita, H; Yoshida, K; Shindoh, M; Ohbuchi, T; Fujinaga, K; Nishimura, M
      Expression of E1AF/PEA3, an ETS-related transcription factor in human non-small-cell lung cancers: Its relevance in cell motility and invasion

      INTERNATIONAL JOURNAL OF CANCER
    22. Legrand, C; Polette, M; Tournier, JM; de Bentzmann, S; Huet, E; Monteau, M; Birembaut, P
      uPA/plasmin system-mediated MMP-9 activation is implicated in bronchial epithelial cell migration

      EXPERIMENTAL CELL RESEARCH
    23. Egelund, R; Petersen, TE; Andreasen, PA
      A serpin-induced extensive proteolytic susceptibility of urokinase-type plasminogen activator implicates distortion of the proteinase substrate-binding pocket and oxyanion hole in the serpin inhibitory mechanism

      EUROPEAN JOURNAL OF BIOCHEMISTRY
    24. Tetu, B; Brisson, J; Wang, CS; Lapointe, H; Beaudry, G; Blanchette, C
      Expression of cathepsin D, stromelysin-3, and urokinase by reactive stromal cells on breast carcinoma prognosis

      CANCER
    25. Wada, M; Wada, NA; Shirono, H; Taniguchi, K; Tsuchie, H; Koga, J
      Amino-terminal fragment of urokinase-type plasminogen activator inhibits HIV-1 replication

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    26. Zhou, L; Hayashi, Y; Itoh, T; Wang, WP; Rui, JA; Itoh, H
      Expression of urokinase-type plasminogen activator, urokinase-type plasminogen activator receptor, and plasminogen activator inhibitor-1 and-2 in hepatocellular carcinoma

      PATHOLOGY INTERNATIONAL
    27. Wittliff, JL; Kunitake, ST; Chu, SS; Travis, JC
      Applications of laser capture microdissection in genomics and proteomics

      JOURNAL OF CLINICAL LIGAND ASSAY
    28. Ree, AH; Pacheco, MM; Tvermyr, M; Fodstad, O; Brentani, MM
      Expression of a novel factor, com1, in early tumor progression of breast cancer

      CLINICAL CANCER RESEARCH
    29. Strojan, P; Budihna, M; Smid, L; Svetic, B; Vrhovec, I; Kos, J; Skrk, J
      Prognostic significance of cysteine proteinases cathepsins B and L and their endogenous inhibitors stefins A and B in patients with squamous cell carcinoma of the head and neck

      CLINICAL CANCER RESEARCH
    30. Katz, BA; Mackman, R; Luong, C; Radika, K; Martelli, A; Sprengeler, PA; Wang, J; Chan, HD; Wong, L
      Structural basis for selectivity of a small molecule, S1-binding, submicromolar inhibitor of urokinase-type plasminogen activator

      CHEMISTRY & BIOLOGY
    31. Tecimer, C; Doering, DL; Goldsmith, LJ; Meyer, JS; Abdulhay, G; Wittliff, JL
      Clinical relevance of urokinase-type plasminogen activator, its receptor and inhibitor type 1 in ovarian cancer

      INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
    32. Okusa, Y; Ichikura, T; Mochizuki, H; Shinomiya, N
      Urokinase type plasminogen activator and its receptor regulates the invasive potential of gastric cancer cell lines

      INTERNATIONAL JOURNAL OF ONCOLOGY
    33. Kotzsch, M; Luther, T; Harbeck, N; Ockert, D; Lutz, V; Noack, E; Grossmann, D; Albrecht, S; Kramer, MD; Lossnitzer, A; Grosser, M; Schmitt, M; Magdolen, V
      New ELISA for quantitation of human urokinase receptor (CD87) in cancer

      INTERNATIONAL JOURNAL OF ONCOLOGY
    34. Thomssen, C; Janicke, F; Kaufmann, M; Scharl, A; Hayes, DF
      Do we need better prognostic factors in node-negative breast cancer? Pro

      EUROPEAN JOURNAL OF CANCER
    35. Kruger, A; Soeltl, R; Lutz, V; Wilhelm, OG; Magdolen, V; Rojo, EE; Hantzopoulos, PA; Graeff, H; Gansbacher, B; Schmitt, M
      Reduction of breast carcinoma tumor growth and lung colonization by overexpression of the soluble urokinase-type plasminogen activator receptor (CD87)

      CANCER GENE THERAPY
    36. Salden, M; Splinter, TAW; Peters, HA; Look, MP; Timmermans, M; van Meerbeeck, JPAM; Foekens, JA
      The urokinase-type plasminogen activator system in resected non-small-celllung cancer

      ANNALS OF ONCOLOGY
    37. Itoh, T; Hayashi, Y; Kanamaru, T; Morita, Y; Suzuki, S; Wang, WP; Zhou, L; Rui, JA; Yamamoto, M; Kuroda, Y; Itoh, H
      Clinical significance of urokinase-type plasminogen activator activity in hepatocellular carcinoma

      JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
    38. Stadler, P; Feldmann, HJ; Creighton, C; Zeilhoffer, HF; Zimmermann, V; Schmitt, M; Molls, M
      Clinical evidence for correlation of insufficient tissue oxygen supply (hypoxia) and tumor-associated proteolysis in squamous cell carcinoma of the head and neck

      INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS
    39. Prechtl, A; Harbeck, N; Thomssen, C; Meisner, C; Braun, M; Untch, M; Wieland, M; Lisboa, B; Cufer, T; Graeff, H; Selbmann, K; Schmitt, M; Janicke, F
      Tumor-biological factors uPA and PAI-1 as stratification criteria of a multicenter adjuvant chemotherapy trial in node-negative breast cancer

      INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS
    40. Harbeck, N; Alt, U; Berger, U; Kates, R; Kruger, A; Thomssen, C; Janicke, F; Graeff, H; Schmitt, M
      Long-term follow-up confirms prognostic impact of PAI-1 and cathepsin D and L in primary breast cancer

      INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS
    41. Noack, F; Schmitt, M; Bauer, J; Helmecke, D; Kruger, W; Thorban, S; Sandherr, M; Kuhn, W; Graeff, H; Harbeck, N
      A new approach to phenotyping disseminated tumor cells: Methodological advances and clinical implications

      INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS
    42. Bouchet, C; Hacene, K; Martin, PM; Becette, V; Tubiana-Hulin, M; Lasry, S; Oglobine, J; Spyratos, F
      Plasminogen activator system type-urokinase and its prognostic impact of adissemination risk index in breast cancer.

      PATHOLOGIE BIOLOGIE
    43. Hildenbrand, R; Leitz, M; Magdolen, V; Luther, T; Albrecht, S; Graeff, H; Stutte, HJ; Bleyl, U; Schmitt, M
      Validation of immunolocalization of the urokinase receptor expression in ductal carcinoma in situ of the breast: comparison with detection by non-isotopic in-situ hybridization

      HISTOPATHOLOGY
    44. Rha, SY; Yang, WI; Gong, SJ; Kim, JJ; Yoo, NC; Roh, JK; Min, JS; Lee, KS; Kim, BS; Chung, HC
      Correlation of tissue and blood plasminogen activation system in breast cancer

      CANCER LETTERS
    45. Zhou, HM; Nichols, A; Meda, P; Vassalli, JD
      Urokinase-type plasminogen activator and its receptor synergize to promotepathogenic proteolysis

      EMBO JOURNAL
    46. Laube, F
      Co-localization of CD44 and urokinase-type plasminogen activator on the surface of human melanoma cells

      ANTICANCER RESEARCH
    47. Yee, LD; Liu, L
      The constitutive production of colony stimulating factor I by invasive human breast cancer cells

      ANTICANCER RESEARCH
    48. Strojan, P; Budihna, M; Smid, L; Vrhovec, I; Skrk, J
      Urokinase-type plasminogen activator, plasminogen activator inhibitor type1 and cathepsin D: Analysis of their prognostic significance in squamous cell carcinoma of the head and neck

      ANTICANCER RESEARCH
    49. Morii, T; Yabe, H; Morioka, H; Yamada, R; Nakagawa, T; Toyama, Y
      Prognostic relevance of urokinase type plasminogen activator, its receptorand inhibitors in chondrosarcoma

      ANTICANCER RESEARCH
    50. Abendstein, B; Daxenbichler, G; Windbichler, G; Zeimet, AG; Geurts, A; Sweep, F; Marth, C
      Predictive value of uPA, PAI-1, HER-2 and VEGF in the serum of ovarian cancer patients

      ANTICANCER RESEARCH
    51. Blasiak, J; Smolarz, B; Kubryn, I; Kulig, A; Dziki, A; Ulanska, J; Pander, B
      Plasminogen activator inhibitor-1 (PAI-1) level and 4G/5G genetic polymorphism in patients with colorectal cancer

      EXPERIMENTAL ONCOLOGY
    52. Fisher, JL; Field, CL; Zhou, H; Harris, TL; Henderson, MA; Choong, PFM
      Urokinase plasminogen activator system gene expression is increased in human breast carcinoma and its bone metastases - A comparison of normal breasttissue, non-invasive and invasive carcinoma and osseous metastases

      BREAST CANCER RESEARCH AND TREATMENT
    53. Mori, T; Abe, T; Wakabayashi, Y; Hikawa, T; Matsuo, K; Yamada, Y; Kuwano, M; Hori, S
      Up-regulation of urokinase-type plasminogen activator and its receptor correlates with enhanced invasion activity of human glioma cells mediated by transforming growth factor-alpha or basic fibroblast growth factor

      JOURNAL OF NEURO-ONCOLOGY
    54. Rosenberger, G; Fuhrmann, G; Grusch, M; Fassl, S; Elford, HL; Smid, K; Peters, GJ; Szekeres, T; Krupitza, G
      The ribonucleotide reductase-inhibitor trimidox induces c-myc and apoptosis of human ovarian carcinoma cells

      LIFE SCIENCES
    55. Inuzuka, K; Ogata, Y; Nagase, H; Shirouzu, K
      Significance of coexpression of urokinase-type plasminogen activator, and matrix metalloproteinase 3 (stromelysin) and 9 (gelatinase B) in colorectalcarcinoma

      JOURNAL OF SURGICAL RESEARCH
    56. Takeuchi, T; Harris, JL; Huang, W; Yan, KW; Coughlin, SR; Craik, CS
      Cellular localization of membrane-type serine protease 1 and identification of protease-activated receptor-2 and single-chain urokinase-type plasminogen activator as substrates

      JOURNAL OF BIOLOGICAL CHEMISTRY
    57. Salame, MY; Samani, NJ; Masood, I; deBono, DP
      Expression of the plasminogen activator system in the human vascular wall

      ATHEROSCLEROSIS
    58. Hjertner, O; Qvigstad, G; Hjorth-Hansen, H; Seidel, C; Woodliff, J; Epstein, J; Waage, A; Sundan, A; Borset, M
      Expression of urokinase plasminogen activator and the urokinase plasminogen activator receptor in myeloma cells

      BRITISH JOURNAL OF HAEMATOLOGY
    59. Kwaan, HC; Wang, J; Svoboda, K; Declerck, PJ
      Plasminogen activator inhibitor 1 may promote tumour growth through inhibition of apoptosis

      BRITISH JOURNAL OF CANCER
    60. Santibanez, JF; Iglesias, M; Frontelo, P; Martinez, J; Quintanilla, M
      Involvement of the Ras/MAPK signaling pathway in the modulation of urokinase production and cellular invasiveness by transforming growth factor-beta(1) in transformed keratinocytes

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    61. Blasiak, J; Smolarz, B
      Plasminogen activator inhibitor-1 (PAI-1) gene 4G/5G promoter polymorphismis not associated with breast cancer

      ACTA BIOCHIMICA POLONICA
    62. Hoffmann, G; Pollow, K; Weikel, W; Strittmatter, HJ; Bach, J; Schaffrath, M; Knapstein, P; Melchert, F; Pollow, B
      Urokinase and plasminogen activator-inhibitor (PAI-1) status in primary ovarian carcinomas and ovarian metastases compared to benign ovarian tumors as a function of histopathological parameters

      CLINICAL CHEMISTRY AND LABORATORY MEDICINE
    63. Irigoyen, JP; Munoz-Canoves, P; Montero, L; Koziczak, M; Nagamine, Y
      The plasminogen activator system: biology and regulation

      CELLULAR AND MOLECULAR LIFE SCIENCES
    64. Swiercz, R; Skrzypczak-Jankun, E; Merrell, MM; Selman, SH; Jankun, J
      Angiostatic activity of synthetic inhibitors of urokinase type plasminogenactivator

      ONCOLOGY REPORTS
    65. Volm, M; Mattern, J; Koomagi, R
      Relationship of urokinase and urokinase receptor in non-small cell lung cancer to proliferation, angiogenesis, metastasis and patient survival

      ONCOLOGY REPORTS
    66. Noack, F; Helmecke, D; Rosenberg, R; Thorban, S; Nekarda, H; Fink, U; Lewald, J; Stich, M; Schutze, K; Harbeck, N; Magdolen, V; Graeff, H; Schmitt, M
      CD87-positive tumor cells in bone marrow aspirates identified by confocal laser scanning fluorescence microscopy

      INTERNATIONAL JOURNAL OF ONCOLOGY
    67. Harbeck, N; Ross, JS; Yurdseven, S; Dettmar, P; Polcher, M; Kuhn, W; Ulm, K; Graeff, H; Schmitt, M
      HER-2/neu gene amplification by fluorescence in situ hybridization allows risk-group assessment in node-negative breast cancer

      INTERNATIONAL JOURNAL OF ONCOLOGY
    68. Miyake, H; Hara, I; Yamanaka, K; Arakawa, S; Kamidono, S
      Elevation of urokinase-type plasminogen activator and its receptor densities as new predictors of disease progression and prognosis in men with prostate cancer

      INTERNATIONAL JOURNAL OF ONCOLOGY
    69. Mohanam, S; Go, Y; Sawaya, R; Venkaiah, B; Mohan, PM; Kouraklis, GP; Gokaslan, ZL; Lagos, GK; Rao, JS
      Elevated levels of urokinase-type plasminogen activator and its receptor during tumor growth in vivo

      INTERNATIONAL JOURNAL OF ONCOLOGY
    70. Fiumelli, H; Jabaudon, D; Magistretti, PJ; Martin, JL
      BDNF stimulates expression, activity and release of tissue-type plasminogen activator in mouse cortical neurons

      EUROPEAN JOURNAL OF NEUROSCIENCE
    71. Aguirre-Ghiso, JA; Frankel, P; Farias, EF; Lu, ZM; Jiang, H; Olsen, A; Feig, LA; Joffe, EB; Foster, DA
      RalA requirement for v-Src- and v-Ras-induced tumorigenicity and overproduction of urokinase-type plasminogen activator: involvement of metalloproteases

      ONCOGENE
    72. Look, MP; Foekens, JA
      Clinical relevance of the urokinase plasminogen activator system in breastcancer

      APMIS
    73. Sendo, F; Araki, Y
      Regulation of leukocyte adherence and migration by glycosylphosphatidyl-inositol-anchored proteins

      JOURNAL OF LEUKOCYTE BIOLOGY
    74. Costelloe, EO; Stacey, KJ; Antalis, TM; Hume, DA
      Regulation of the plasminogen activator inhibitor-2 (PAI-2) gene in murinemacrophages. Demonstration of a novel pattern of responsiveness to bacterial endotoxin

      JOURNAL OF LEUKOCYTE BIOLOGY
    75. Sandstrom, M; Johansson, M; Sandstrom, J; Bergenheim, AT; Henriksson, R
      Expression of the proteolytic factors, tPA and uPA, PAI-1 and VEGF during malignant glioma progression

      INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE
    76. Santibanez, JF; Frontelo, P; Iglesias, M; Martinez, J; Quintanilla, M
      Urokinase expression and binding activity associated with the transforminggrowth factor beta(1)-induced migratory and invasive phenotype of mouse epidermal keratinocytes

      JOURNAL OF CELLULAR BIOCHEMISTRY
    77. Miralles, F; Ibanez-Tallon, I; Parra, M; Crippa, M; Blasi, F; Besser, D; Nagamine, Y; Munoz-Canoves, P
      Transcriptional regulation of the murine urokinase-type plasminogen activator gene in skeletal myoblasts

      THROMBOSIS AND HAEMOSTASIS
    78. Miyake, H; Hara, I; Yamanaka, K; Gohji, K; Arakawa, S; Kamidono, S
      Elevation of serum levels of urokinase-type plasminogen activator and its receptor is associated with disease progression and prognosis in patients with prostate cancer

      PROSTATE
    79. Moriyama, T; Kataoka, H; Hamasuna, R; Yoshida, E; Sameshima, T; Iseda, T; Yokogami, K; Nakano, S; Koono, M; Wakisaka, S
      Simultaneous up-regulation of urokinase-type plasminogen activator (uPA) and uPA receptor by hepatocyte growth factor/scatter factor in human glioma cells

      CLINICAL & EXPERIMENTAL METASTASIS
    80. Miskin, R; Masos, T; Yahav, S; Shinder, D; Globerson, A
      alpha MUPA mice: a transgenic model for increased life span

      NEUROBIOLOGY OF AGING
    81. Zhang, LP; Takahara, T; Yata, Y; Furui, K; Jin, B; Kawada, N; Watanabe, A
      Increased expression of plasminogen activator and plasminogen activator inhibitor during liver fibrogenesis of rats: role of stellate cells

      JOURNAL OF HEPATOLOGY
    82. Harbeck, N; Thomssen, C; Berger, U; Ulm, K; Kates, RE; Hofler, H; Janicke, F; Graeff, H; Schmitt, M
      Invasion marker PAI-1 remains a strong prognostic factor after long-term follow-up both for primary breast cancer and following first relapse

      BREAST CANCER RESEARCH AND TREATMENT
    83. Carroll, VA; Binder, BR
      The role of the plasminogen activation system in cancer

      SEMINARS IN THROMBOSIS AND HEMOSTASIS
    84. Shumilla, JA; Barchowsky, A
      Inhibition of protein synthesis by Chromium(VI) differentially affects expression of urokinase and its receptor in human type II pneumocytes

      TOXICOLOGY AND APPLIED PHARMACOLOGY
    85. Ossowski, L; Ghiso, JA; Liu, D; Yu, W; Kovalski, K
      The role of plasminogen activator receptor in cancer invasion and dormancy

      MEDICINA-BUENOS AIRES
    86. Imao, T; Koshida, K; Endo, Y; Uchibayashi, T; Sasaki, T; Namiki, M
      Dominant role of E-cadherin in the progression of bladder cancer

      JOURNAL OF UROLOGY
    87. Hendrickson, RJ; Okada, SS; Cahill, PA; Yankah, E; Sitzmann, JV; Redmond, EM
      Ethanol inhibits basal and flow-induced vascular smooth muscle cell migration in vitro

      JOURNAL OF SURGICAL RESEARCH
    88. Albo, D; Berger, DH; Rothman, VL; Tuszynski, GP
      Role of urokinase plasminogen activator receptor in thrombospondin 1-mediated tumor cell invasion

      JOURNAL OF SURGICAL RESEARCH
    89. Nakada, M; Yamashita, J; Okada, Y; Sato, H
      Ets-1 positively regulates expression of urokinase-type plasminogen activator (uPA) and invasiveness of astrocytic tumors

      JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
    90. Hibino, T; Matsuda, Y; Takahashi, T; Goetinck, PF
      Suppression of keratinocyte proliferation by plasminogen activator inhibitor-2

      JOURNAL OF INVESTIGATIVE DERMATOLOGY
    91. Werther, K; Normark, M; Hansen, BF; Nielsen, HJ
      Immunoglobulin and enzyme-conjugated dextran polymers enhance u-PAR staining intensity of carcinoma cells in peripheral blood smears

      JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY
    92. Kohler, U; Martin, R; Pippig, S; Horn, LC
      Urokinase-type plasminogen activator and its inhibitor PAI-1 as prognosticfactors in cervical cancer

      GEBURTSHILFE UND FRAUENHEILKUNDE
    93. Yebra, M; Goretzki, L; Pfeifer, M; Mueller, BM
      Urokinase-type plasminogen activator binding to its receptor stimulates tumor cell migration by enhancing integrin-mediated signal transduction

      EXPERIMENTAL CELL RESEARCH
    94. Ghiso, JAA; Alonso, DF; Farias, EF; Gomez, DE; Joffe, EBD
      Deregulation of the signaling pathways controlling urokinase production - Its relationship with the invasive phenotype

      EUROPEAN JOURNAL OF BIOCHEMISTRY
    95. Reuning, U; Guerrini, L; Nishiguchi, T; Page, S; Seibold, H; Magdolen, V; Graeff, H; Schmitt, M
      Rel transcription factors contribute to elevated urokinase expression in human ovarian carcinoma cells

      EUROPEAN JOURNAL OF BIOCHEMISTRY
    96. Garbett, EA; Reed, MWR; Brown, NJ
      Proteolysis in human breast and colorectal cancer

      BRITISH JOURNAL OF CANCER
    97. Harbeck, N; Dettmar, P; Thomssen, C; Berger, U; Ulm, K; Kates, R; Hofler, H; Janicke, F; Graeff, H; Schmitt, M
      Risk group discrimination in node-negative breast cancer using invasion and proliferation markers: 6-year median follow up

      BRITISH JOURNAL OF CANCER
    98. Broet, P; Spyratos, F; Romain, S; Quillien, V; Daver, A; Ricolleau, G; Rallet, A; Toulas, C; Asselain, B
      Prognostic value of uPA and p53 accumulation measured by quantitative biochemical assays in 1245 primary breast cancer patients: a multicentre study

      BRITISH JOURNAL OF CANCER
    99. Jahkola, T; Toivonen, T; von Smitten, K; Virtanen, I; Wasenius, VM; Blomqvist, C
      Cathepsin-D, urokinase plasminogen activator and type-1 plasminogen activator inhibitor in early breast cancer: an immunohistochemical study of prognostic value and relations to tenascin-C and other factors

      BRITISH JOURNAL OF CANCER
    100. Ferrier, CM; de Witte, HH; Straatman, H; van Tienoven, DH; van Geloof, WL; Rietveld, FJR; Sweep, CGJ; Ruiter, DJ; van Muijen, GNP
      Comparison of immunohistochemistry with immunoassay (ELISA) for the detection of components of the plasminogen activation system in human tumour tissue

      BRITISH JOURNAL OF CANCER


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 04/08/20 alle ore 11:41:39